These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1953780)

  • 41. Central and regional hemodynamic effects during infusion of Big endothelin-1 in healthy humans.
    Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
    J Appl Physiol (1985); 1996 Jun; 80(6):1921-7. PubMed ID: 8806895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction.
    Amuchastegui CS; Remuzzi G; Perico N
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F839-44. PubMed ID: 7977788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
    Duranteau J; Pussard E; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelin-1 produces heterogeneous regional haemodynamic effects in conscious rabbits.
    Roberts-Thomson P; McRitchie RJ; Chalmers JP
    Clin Exp Hypertens; 1996 Feb; 18(2):145-69. PubMed ID: 8868998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional hemodynamics during postexercise hypotension. I. Splanchnic and renal circulations.
    Pricher MP; Holowatz LA; Williams JT; Lockwood JM; Halliwill JR
    J Appl Physiol (1985); 2004 Dec; 97(6):2065-70. PubMed ID: 15310744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1995 Apr; 25(4 Pt 1):620-5. PubMed ID: 7721406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of somatostatin on organ blood flow in anaesthetized cats.
    Hamar J; Iripchanov BB; Demchenko IT; Dézsi L; Moskalenko JJ
    Acta Physiol Hung; 1985; 65(1):47-51. PubMed ID: 2859734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in regional vascular sensitivity to endothelin-1 between spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Wright CE; Fozard JR
    Br J Pharmacol; 1990 May; 100(1):107-13. PubMed ID: 1973622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of endothelin on rat mesenteric microvessels].
    Zhang J; Jiang H; Fan G; Tang J; Tang CS
    Sheng Li Xue Bao; 1991 Feb; 43(1):98-101. PubMed ID: 2038674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin-1 in the pithed rat.
    MacLean MR; Randall MD; Hiley CR
    Br J Pharmacol; 1989 Nov; 98(3):1055-65. PubMed ID: 2511990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine.
    Stebbins CL; Symons JD
    J Appl Physiol (1985); 1995 Jan; 78(1):185-90. PubMed ID: 7713810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of controlled ventilation on renal and splanchnic blood flows during nicotine.
    Bedran de Castro MT; Downey HF; Crystal GJ; Bashour FA
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H360-5. PubMed ID: 3976905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
    Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac and regional haemodynamic effects of endothelin-1 in rats subjected to critical haemorrhagic hypotension.
    Jochem J; Zwirska-Korczala K; Gwóźdź B; Walichiewicz P; Jośko J
    J Physiol Pharmacol; 2003 Sep; 54(3):383-96. PubMed ID: 14566077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
    Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
    Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin: a potent renal and systemic vasoconstrictor peptide.
    King AJ; Brenner BM; Anderson S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1051-8. PubMed ID: 2660593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Splanchnic and renal contributions to circulatory homeostasis in sodium depletion.
    Echtenkamp SF; Davis JO; Freeman RH; Dietz JR; Villarreal D
    Am J Physiol; 1983 Oct; 245(4):H573-9. PubMed ID: 6353943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restoration of renal and mesenteric hemodynamics by felodipine in a canine model of hemorrhagic shock.
    Sabouni M; Hodge K; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):465-70. PubMed ID: 3405320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin.
    Madeddu P; Yang XP; Anania V; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F304-11. PubMed ID: 2201205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide.
    Gasic S; Wagner OF; Vierhapper H; Nowotny P; Waldhäusl W
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):176-80. PubMed ID: 1376785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.